跳至主要内容
临床试验/ACTRN12624000458538
ACTRN12624000458538尚未招募Unknown

Investigating the effect of Er-YAG Surgical Laser on Stress Urinary Incontinence symptoms in adult women – a randomised control trial.

Anna Rosamilia0 个研究点目标入组 147 人开始时间: 2024年4月15日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
147

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Adult Female, 18 years of age or older
  • Slight to severe stress urinary incontinence, based on the Severity Index for Urinary Incontinence in women.
  • No significant improvement in urinary incontinence from at least one previous conservative treatment, such as pelvic floor muscle training
  • Capable of providing informed consent and able to return for follow-up.
  • Normal Cervical screening test within last five years

排除标准

  • Very severe stress urinary incontinence, based on the Severity Index for Urinary Incontinence in women.
  • Diagnosis of OAB wet, based on UDI-6, question 2 urine leakage related to the feeling of urgency” – answer Moderately OR Greatly”.
  • Presence of vesicovaginal fistula
  • Fecal incontinence
  • Pregnant subjects or women less than 12-months post-partum
  • Actively breastfeeding or ceased breastfeeding less than three menstrual cycles
  • Any previous prolapse surgery
  • Any previous incontinence surgery
  • Any radical pelvic surgery
  • Transvaginal mesh or sling implant
  • Pre-existing bladder pathology including prior radiation treatment.
  • Previous surgery in the treatment area in the last year.
  • Active genital infection
  • Subject presenting with a cervical screening test demonstrating cervical dysplasia or another reason for colposcopic assessment
  • Systemic steroids use within the last 3 months
  • Pelvic organ prolapse (POP) > stage 2 according to pelvic organ prolapse quantification system
  • Diagnosis of collagen disorders eg. Benign joint hypermobility/Ehlers-Danlos/Marfan etc.
  • Serious systemic disease or any chronic condition that could interfere with study compliance.
  • Any other reason that, in the opinion of the investigator, prevents the subject from participating in the study or compromise the subject safety.
  • Other contraindications to laser treatment: UTI, injury or bleeding in areas of tissue to be treated (vestibule and anterior vaginal wall), Morbid obesity (BMI>40), Diabetes, A history of Photosensivity disorder or use of photosensitivity medications, abnormal scarring, excessive sun exposure, preoperative histology findings indicative of malignancy.
  • Unwillingness or inability to complete follow-up schedule
  • Unwillingness or inability to give Informed Consent

研究者

相似试验